UnknownPhase 2NCT04225195

Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis

Studying Aspergillosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Principal Investigator
mingui wang
Huashan Hospital affiliated to Fudan University ,Shanghai, China
Intervention
Amphotericin B cholesteryl sulfate complex for injection(ABCD)(drug)
Enrollment
60 enrolled
Eligibility
18-100 years · All sexes
Timeline
20202022

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04225195 on ClinicalTrials.gov

Other trials for Aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Aspergillosis

← Back to all trials